BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24964891)

  • 1. Racial/ethnic differences in hip and diaphyseal femur fractures.
    Lo JC; Zheng P; Grimsrud CD; Chandra M; Ettinger B; Budayr A; Lau G; Baur MM; Hui RL; Neugebauer R
    Osteoporos Int; 2014 Sep; 25(9):2313-8. PubMed ID: 24964891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnic differences in composite indices of femoral neck strength.
    Ishii S; Cauley JA; Greendale GA; Danielson ME; Safaei Nili N; Karlamangla A
    Osteoporos Int; 2012 Apr; 23(4):1381-90. PubMed ID: 21927926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
    Black DM; Geiger EJ; Eastell R; Vittinghoff E; Li BH; Ryan DS; Dell RM; Adams AL
    N Engl J Med; 2020 Aug; 383(8):743-753. PubMed ID: 32813950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy.
    Lo JC; Hui RL; Grimsrud CD; Chandra M; Neugebauer RS; Gonzalez JR; Budayr A; Lau G; Ettinger B
    Bone; 2016 Apr; 85():142-7. PubMed ID: 26769007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial and ethnic differences in hip fracture outcomes in men.
    Liu LH; Chandra M; Gonzalez JR; Lo JC
    Am J Manag Care; 2017 Sep; 23(9):560-564. PubMed ID: 29087156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City.
    Fang J; Freeman R; Jeganathan R; Alderman MH
    Ethn Dis; 2004; 14(2):280-4. PubMed ID: 15132215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic factors in hip fracture incidence and mortality rates in California, 2000-2011.
    Sullivan KJ; Husak LE; Altebarmakian M; Brox WT
    J Orthop Surg Res; 2016 Jan; 11():4. PubMed ID: 26746904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of atypical nontraumatic diaphyseal fractures of the femur.
    Dell RM; Adams AL; Greene DF; Funahashi TT; Silverman SL; Eisemon EO; Zhou H; Burchette RJ; Ott SM
    J Bone Miner Res; 2012 Dec; 27(12):2544-50. PubMed ID: 22836783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are race and sex associated with the occurrence of atypical femoral fractures?
    Marcano A; Taormina D; Egol KA; Peck V; Tejwani NC
    Clin Orthop Relat Res; 2014 Mar; 472(3):1020-7. PubMed ID: 24166075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.
    Napoli N; Jin J; Peters K; Wustrack R; Burch S; Chau A; Cauley J; Ensrud K; Kelly M; Black DM
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2414-22. PubMed ID: 22547423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of subtrochanteric fracture criteria on hip fracture classification.
    Huang SY; Grimsrud CD; Provus J; Hararah M; Chandra M; Ettinger B; Lo JC
    Osteoporos Int; 2012 Feb; 23(2):743-50. PubMed ID: 21562878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
    Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
    J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of atypical femoral fracture.
    Lo JC; Huang SY; Lee GA; Khandelwal S; Provus J; Ettinger B; Gonzalez JR; Hui RL; Grimsrud CD
    Bone; 2012 Jul; 51(1):181-4. PubMed ID: 22414379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.
    Abrahamsen B; Eiken P; Eastell R
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5258-65. PubMed ID: 20843943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.
    Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS
    Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for subtrochanteric and diaphyseal fractures: the study of osteoporotic fractures.
    Napoli N; Schwartz AV; Palermo L; Jin JJ; Wustrack R; Cauley JA; Ensrud KE; Kelly M; Black DM
    J Clin Endocrinol Metab; 2013 Feb; 98(2):659-67. PubMed ID: 23345099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragility fractures of the hip and femur: incidence and patient characteristics.
    Nieves JW; Bilezikian JP; Lane JM; Einhorn TA; Wang Y; Steinbuch M; Cosman F
    Osteoporos Int; 2010 Mar; 21(3):399-408. PubMed ID: 19484169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure.
    Lo JC; Grimsrud CD; Ott SM; Chandra M; Hui RL; Ettinger B
    Osteoporos Int; 2019 Dec; 30(12):2515-2520. PubMed ID: 31555883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women.
    Khandelwal S; Chandra M; Lo JC
    Bone; 2012 Dec; 51(6):1025-8. PubMed ID: 22921875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic difference of clinical vertebral fracture risk.
    Bow CH; Cheung E; Cheung CL; Xiao SM; Loong C; Soong C; Tan KC; Luckey MM; Cauley JA; Fujiwara S; Kung AW
    Osteoporos Int; 2012 Mar; 23(3):879-85. PubMed ID: 21461720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.